Cell and gene therapies hold revolutionary potential for treating a wide range of diseases. However, operationalizing trials of such duration and complexity is a significant task. Their development demands meticulous planning and expertise across multiple disciplines.
Cell and gene therapy clinical trials involve unique operational challenges compared to traditional clinical studies. These trials often require specialized clinical sites, complex manufacturing and logistics processes, and close coordination between sponsors, CROs, and multiple vendors involved in the trial.
In addition, CGT trials frequently involve long-term patient monitoring and follow-up to evaluate treatment durability and safety. Successfully operationalizing these trials requires careful planning across regulatory strategy, site readiness, product logistics, clinical data management, and patient engagement.
View this webinar to hear from Allucents operational A-Team as they share insights and strategies on how to successfully conduct cell and gene therapy clinical trials. Learn proactive strategies for managing logistics, startup procedures, data management, regulatory compliance, and patient engagement. Prepare to pave the way for successful CGT trials with expert guidance.
What this Webinar Covers
- Overview of the current cell and gene therapy clinical trial landscape
- Key operational considerations for conducting CGT trials
- Regulatory and study startup considerations
- Site selection and infrastructure requirements for CGT studies
- Managing complex product logistics and supply chains
- Clinical data management strategies for CGT trials
- Patient engagement and long-term follow-up approaches
Request a Proposal
Share This
